StonvexLoading…
StonvexStonvexStonvexCore line items from ALIT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.26B | $2.33B | $2.39B | $2.21B |
Operating Income | $-3.09B | $-90.00M | $-81.00M | $-94.00M |
Net Income | $-3.10B | $-157.00M | $-345.00M | $-62.00M |
EPS (Diluted) | $-5.87 | $-0.29 | $-0.70 | $-0.14 |
Total Assets | $4.57B | $8.19B | $10.78B | $11.23B |
Total Liabilities | $3.52B | $3.88B | $6.04B | $6.15B |
Cash & Equivalents | $273.00M | $343.00M | $324.00M | $228.00M |
Free Cash Flow OCF − CapEx | $250.00M | $131.00M | $246.00M | $155.00M |
Shares Outstanding | 527.57M | 540.37M | 489.46M | 458.56M |